Forbes July 21, 2020
Some areas of wearable technology have struggled to find a purpose.
The clearest is the smartwatch, still routinely used for little more than fitness tracking and phone notifications.
Movano is working on one of the more life-changing uses for wearables, completely non-invasive glucose monitoring for people with diabetes.
The company recently picked up an additional $10 million in funding, and plans to have a working prototype by the end of 2021.
Movano’s specific hook is not just that it requires no fingerpick or cannula to acquire a reading, but it comes in the form of a watch.
Currently only rendered images of the device are available. However, these clearly show Movano wants this to be a watch you might wear...